Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer?
Default Text Formatting for This Field
Default Text Formatting for This Field
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsBenefit of brachytherapy in patients with early-stage prostate cancer is still unclear
It remains an unresolved issue as to whether interstitial brachytherapy has advantages compared to other therapy options in men with localized prostate cancer, nor do newer studies provide proof in this respect. This is…
12 January 2011
NewsHormone therapy use by postmenopausal women may increase incidence of more advanced breast cancer
Follow-up of about 11 years of participants in the Women's Health Initiative finds that among postmenopausal women, use of estrogen plus progestin is associated with an increased incidence of breast cancers that are…
20 October 2010
NewsNew targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer
A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of…
